CD8 knockout mice are protected from challenge by vaccination with WR201, a live attenuated mutant of brucella melitensis

Clinical and Developmental Immunology

Volumn 2013, Issue , 2013, Pages

  Yingst, Samuel L ^a,b   Izadjoo, Mina ^c   Hoover, David L ^d  

^a WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^b ARMED FORCES RESEARCH INSTITUTE OF MEDICAL SCIENCES   (Thailand)

^c Diagnostic and Translational Research Center   (United States)

^d DHMD Consulting   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; BRUCELLA VACCINE; CD8 ANTIGEN; FAS ANTIGEN; GAMMA INTERFERON; LIVE VACCINE; PERFORIN; UNCLASSIFIED DRUG; WR 201 VACCINE;

ADHERENT CELL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY BLOOD LEVEL; ARTICLE; BACTERIAL CLEARANCE; BACTERIAL IMMUNITY; BACTERIAL VIRULENCE; BRUCELLA MELITENSIS; BRUCELLOSIS; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; COLONY FORMING UNIT; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS; HUMORAL IMMUNITY; KNOCKOUT MOUSE; LUNG INFECTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SERUM BACTERICIDAL ANTIBODY ASSAY; SHAM PROCEDURE; SPLEEN DISEASE; SPLEEN LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; VACCINATION; ANIMAL; DISEASE MODEL; GENETICS; IMMUNIZATION; IMMUNOLOGY; METABOLISM;

ANIMALS; ANTIGENS, CD8; BRUCELLA MELITENSIS; BRUCELLA VACCINE; BRUCELLOSIS; DISEASE MODELS, ANIMAL; IMMUNITY, CELLULAR; IMMUNITY, HUMORAL; IMMUNIZATION; MALE; MICE; MICE, KNOCKOUT;

EID: 84888877729     PISSN: 17402522     EISSN: 17402530     Source Type: Journal    
DOI: 10.1155/2013/686919     Document Type: Article

References (39)

1. Boschiroli M. L., Foulongne V., O'Callaghan D., Brucellosis: a worldwide zoonosis. Current Opinion in Microbiology 2001 4 1 58 64 2-s2.0-0035155006 10.1016/S1369-5274(00)00165-X (Pubitemid 32126898)
2. Godfroid J., Käsbohrer A., Brucellosis in the European Union and Norway at the turn of the twenty-first century. Veterinary Microbiology 2002 90 1-4 135 145 2-s2.0-0037146710 10.1016/S0378-1135(02)00217-1 (Pubitemid 35279873)
3. Moreno E., Brucellosis in Central America. Veterinary Microbiology 2002 90 1-4 31 38 2-s2.0-0037146712 10.1016/S0378-1135(02)00242-0 (Pubitemid 35279866)
4. Refai M., Incidence and control of brucellosis in the Near East region. Veterinary Microbiology 2002 90 1-4 81 110 2-s2.0-0037146666 10.1016/S0378-1135(02)00248-1 (Pubitemid 35279871)
5. Banai M., Control of small ruminant brucellosis by use of Brucella melitensis Rev.1 vaccine: laboratory aspects and field observations. Veterinary Microbiology 2002 90 1-4 497 519 2-s2.0-0037146616 10.1016/S0378-1135(02)00231-6 (Pubitemid 35279898)
6. Robinson-Dunn B., The microbiology laboratory's role in response to bioterrorism. Archives of Pathology and Laboratory Medicine 2002 126 3 291 294 2-s2.0-0036188566 (Pubitemid 34208118)
7. Montaraz J. A., Winter A. J., Comparison of living and nonliving vaccines for Brucella abortus in BALB/c mice. Infection and Immunity 1986 53 2 245 251 2-s2.0-0022468107 (Pubitemid 16073848)
8. + T cells by Brucella infection or immunization with antigenic extracts. Infection and Immunity 1995 63 3 969 975 2-s2.0-0028953647
9. Corbel M. J., Brucellosis: an overview. Emerging Infectious Diseases 1997 3 2 213 221 2-s2.0-0031111368 (Pubitemid 127431682)
10. Aldomy F. M. M., Jahans K. L., Altarazi Y. H., Isolation of Brucella melitensis from aborting ruminants in Jordan. Journal of Comparative Pathology 1992 107 2 239 242 2-s2.0-0026705666 10.1016/0021-9975(92)90040-2
11. Cheville N. F., Development, testing and commercialization of a new brucellosis vaccine for cattle. Annals of the New York Academy of Sciences 2000 916 147 153 2-s2.0-0034531336 (Pubitemid 32061087)
12. Hoover D. L., Crawford R. M., van de Verg L. L., Izadjoo M. J., Bhattacharjee A. K., Paranavitana C. M., Warren R. L., Nikolich M. P., Hadfield T. L., Protection of mice against brucellosis by vaccination with Brucella melitensis WR201 (16MΔ purEK). Infection and Immunity 1999 67 11 5877 5884 2-s2.0-0032750805 (Pubitemid 29508113)
13. Cheers C., Ho M., Resistance and susceptibility of mice to bacterial infection. IV. Functional specificity in natural resistance to facultative intracellular bacteria. RES Journal of the Reticuloendothelial Society 1983 34 4 299 309 2-s2.0-0021030085 (Pubitemid 14249468)
14. Plommet M., Plommet A. M., Immune serum-mediated effects on brucellosis evolution in mice. Infection and Immunity 1983 41 1 97 105 2-s2.0-0020533156 (Pubitemid 13063024)
15. Araya L. N., Elzer P. H., Rowe G. E., Enright F. M., Winter A. J., Temporal development of protective cell-mediated and humoral immunity in BALB/c mice infected with Brucella abortus. Journal of Immunology 1989 143 10 3330 3337 2-s2.0-0024368661 (Pubitemid 20010164)
16. He Y., Vemulapalli R., Zeytun A., Schurig G. G., Induction of specific cytotoxic lymphocytes in mice vaccinated with Brucella abortus RB51. Infection and Immunity 2001 69 9 5502 5508 2-s2.0-0034868617 10.1128/IAI.69.9.5502-5508. 2001 (Pubitemid 32786485)
17. Murphy E. A., Sathiyaseelan J., Parent M. A., Zou B., Baldwin C. L., Interferon- γ is crucial for surviving a Brucella abortus infection in both resistant C57BL/6 and susceptible BALB/c mice. Immunology 2001 103 4 511 518 2-s2.0-0034886064 10.1046/j.1365-2567.2001.01258.x (Pubitemid 32744399)
18. Fernandes D. M., Jiang X., Jung J. H., Baldwin C. L., Comparison of T cell cytokines in resistant and susceptible mice infected with virulent Brucella abortus strain 2308. FEMS Immunology and Medical Microbiology 1996 16 3-4 193 203 2-s2.0-0030608475 10.1016/S0928-8244(96)00083-1 (Pubitemid 27041955)
19. Zhan Y., Yang J., Cheers C., Cytokine response of T-cell subsets from Brucella abortus -infected mice to soluble Brucella proteins. Infection and Immunity 1993 61 7 2841 2847 2-s2.0-0027258598 (Pubitemid 23182277)
20. + T cells as well as systemic and oral protection against Brucella abortus infection. Infection and Immunity 2009 77 1 436 445 2-s2.0-58449120792 10.1128/IAI.01151-08
21. Goel D., Rajendran V., Ghosh P. C., Bhatnagar R., Cell mediated immune response after challenge in Omp25 liposome immunized mice contributes to protection against virulent Brucella abortus 544. Vaccine 2013 31 8 1231 1237 10.1016/j.vaccine.2012.12.043
22. + cytotoxic T cell response. Vaccine 2010 28 12 2408 2415 2-s2.0-77249178689 10.1016/j.vaccine.2009.12.076
23. Brandão A. P. M. S., Oliveira F. S., Carvalho N. B., Vieira L. Q., Azevedo V., MacEdo G. C., Oliveira S. C., Host susceptibility to Brucella abortus infection is more pronounced in IFN- γ knockout than IL-12/ β 2-microglobulin double-deficient mice. Clinical and Developmental Immunology 2012 2012 7 2-s2.0-84855583666 10.1155/2012/589494 589494
24. + T cell responses. Cellular Microbiology 2013 15 4 487 502 10.1111/cmi.12058
25. + T cells contribute to persistence of brucellosis. PLoS ONE 2012 7 4 e34925 10.1371/journal.pone.0034925
26. Durward M. A., Harms J., Magnani D. M., Eskra L., Splitter G. A., Discordant Brucella melitensis antigens yield cognate CD8 T cells in vivo. Infection and Immunity 2010 78 1 168 176 2-s2.0-73449121465 10.1128/IAI.00994-09
27. + T cell, B cell, Th2, and Th17 responses in the control of Brucella melitensis infection in mice. Infection and Immunity 2012 80 12 4271 4280 10.1128/IAI.00761-12
28. Izadjoo M. J., Bhattacharjee A. K., Paranavitana C. M., Hadfield T. L., Hoover D. L., Oral vaccination with Brucella melitensis WR201 protects mice against intranasal challenge with virulent Brucella melitensis 16M. Infection and Immunity 2004 72 7 4031 4039 2-s2.0-3042594716 10.1128/IAI.72.7.4031-4039. 2004 (Pubitemid 38821918)
29. Izadjoo M. J., Polotsky Y., Mense M. G., Bhattacharjee A. K., Paranavitana C. M., Hadfield T. L., Hoover D. L., Impaired control of Brucella melitensis infection in Rag1-deficient mice. Infection and Immunity 2000 68 9 5314 5320 2-s2.0-0033863453 10.1128/IAI.68.9.5314-5320.2000
30. lo T lymphocytes control intracellular Brucella abortus infection as demonstrated in major histocompatibility complex class I- and class II-deficient mice. European Journal of Immunology 1995 25 9 2551 2557 2-s2.0-0029119977 10.1002/eji.1830250922
31. Pavlov H., Hogarth M., McKenzie F. C., Cheers C., In vivo and in vitro effects of monoclonal antibody to Ly antigens on immunity to infection. Cellular Immunology 1982 71 1 127 138 2-s2.0-0019971385 (Pubitemid 12032752)
32. + T cells by B7-transfected melanoma cells. Science 1993 259 5093 368 370 2-s2.0-0027392843 (Pubitemid 23055679)
33. + T cell in the immune response to Brucella melitensis in mice [Ph.D. thesis] 2003 Department of Basic Medical Sciences, Purdue University School of Veterinary Medicine
34. Soloski M. J., Szperka M. E., Davies A., Wooden S. L., Host immune response to intracellular bacteria: a role for MHC-linked class-Ib antigen-presenting molecules. Experimental Biology and Medicine 2000 224 4 231 239 2-s2.0-0033900394 (Pubitemid 30643500)
35. Murphy E. A., Parent M., Sathiyaseelan J., Jiang X., Baldwin C. L., Immune control of Brucella abortus 2308 infections in BALB/c mice. FEMS Immunology and Medical Microbiology 2001 32 1 85 88 2-s2.0-0035666325 10.1016/S0928-8244(01)00278-4 (Pubitemid 34025079)
36. Wonnacott K. M., Bonneau R. H., The effects of stress on memory cytotoxic T lymphocyte-mediated protection against herpes simplex virus infection at mucosal sites. Brain, Behavior, and Immunity 2002 16 2 104 117 2-s2.0-0036447005 10.1006/brbi.2001.0624 (Pubitemid 35425568)
37. Forestier C., Deleuil F., Lapaque N., Moreno E., Gorvel J. P., Brucella abortus lipopolysaccharide in murine peritoneal macrophages acts as a down-regulator of T cell activation. Journal of Immunology 2000 165 9 5202 5210 2-s2.0-0034327811
38. Eze M. O., Yuan L., Crawford R. M., Paranavitana C. M., Hadfield T. L., Bhattacharjee A. K., Warren R. L., Hoover D. L., Effects of opsonization and γ interferon on growth of Brucella melitensis 16M in mouse peritoneal macrophages in vitro. Infection and Immunity 2000 68 1 257 263 2-s2.0-0033981499 (Pubitemid 30016705)
39. Jiang X., Baldwin C. L., Effects of cytokines on intracellular growth of Brucella abortus. Infection and Immunity 1993 61 1 124 134 2-s2.0-0027455498 (Pubitemid 23015408)